Skip to content

Author

L. M. Villar

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Ultrasensitive quantification links higher serum interferon-α and interferon-γ levels with lower leukocyte and lymphocyte counts in lupus.

OBJECTIVES Hematological abnormalities are common in systemic lupus erythematosus (SLE). Interferon-α (IFN-α) and interferon-γ (IFN-γ) play pivotal roles in the immunopathogenesis of SLE. However, their measurement in serum has long been limited by their extremely low circulating concentrations. With the advent of ultr...

Marta Rodríguez-García, F. Gómez-Bernal, J. C. Quevedo-Abeledo et al. · 0 citations
Open access Sep 2026

Ultrasensitive serum levels of interleukin 13 in systemic lupus erythematosus patients: a cross-sectional study

Since IL-13 was associated with an adverse lipid profile, its inverse relationship with augmentation index suggests that its cardiovascular effects may be at least partially independent of circulating lipids.

I. Ferraz-Amaro, J. C. Quevedo-Abeledo, B. Tejera-Segura et al. · 0 citations
Open access Nov 2026

Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis

It is found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity.

I. Ferraz-Amaro, J. C. Quevedo-Abeledo, Enrique García-Barrera et al. · 0 citations
Open access Sep 2026

Interleukin-22 reflects adverse cardiometabolic features in SLE

Abstract Introduction Interleukin-22 (IL-22), a member of the IL-10 cytokine family, primarily targets non-haematopoietic epithelial and stromal cells, contributing to maintenance of epithelial barrier integrity, antimicrobial immunity and tissue regeneration. In this study, we sought to evaluate the association betwee...

I. Ferraz-Amaro, J. C. Quevedo-Abeledo, B. Tejera-Segura et al. · 0 citations
Open access Sep 2026

Ultrasensitive quantification of serum IL-5 in systemic lupus erythematosus does not reveal utility as a biomarker for disease activity or damage

Background Interleukin-5 (IL-5) is the principal regulator of eosinophil biology and a key mediator of type 2 immune responses. Despite its recognized role in autoimmunity, its contribution to the pathophysiology of systemic lupus erythematosus (SLE) remains poorly defined, and no previous study has quantified IL-5 usi...

I. Ferraz-Amaro, J. C. Quevedo-Abeledo, B. Tejera-Segura et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.